These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 25112775)

  • 1. Circulating hematopoietic progenitor cells in essential thrombocythemia versus prefibrotic/early primary myelofibrosis.
    Geissler K; Jäger E; Gisslinger B; Thiele J; Schwarzinger I; Gisslinger H
    Am J Hematol; 2014 Dec; 89(12):1157-8. PubMed ID: 25112775
    [No Abstract]   [Full Text] [Related]  

  • 2. Current diagnostic criteria for the chronic myeloproliferative disorders (MPD) essential thrombocythemia (ET), polycythemia vera (PV) and chronic idiopathic myelofibrosis (CIMF).
    Michiels JJ; Bernema Z; Van Bockstaele D; De Raeve H; Schroyens W
    Pathol Biol (Paris); 2007 Mar; 55(2):92-104. PubMed ID: 16919893
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Practical application and clinical impact of the WHO histopathological criteria on bone marrow biopsy for the diagnosis of essential thrombocythemia versus prefibrotic primary myelofibrosis.
    Brousseau M; Parot-Schinkel E; Moles MP; Boyer F; Hunault M; Rousselet MC
    Histopathology; 2010 May; 56(6):758-67. PubMed ID: 20546341
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relevance of bone marrow features in the differential diagnosis between essential thrombocythemia and early stage idiopathic myelofibrosis.
    Thiele J; Kvasnicka HM; Zankovich R; Diehl V
    Haematologica; 2000 Nov; 85(11):1126-34. PubMed ID: 11064463
    [TBL] [Abstract][Full Text] [Related]  

  • 5. JAK2(V617F) allele burden discriminates essential thrombocythemia from a subset of prefibrotic-stage primary myelofibrosis.
    Hussein K; Bock O; Theophile K; von Neuhoff N; Buhr T; Schlué J; Büsche G; Kreipe H
    Exp Hematol; 2009 Oct; 37(10):1186-1193.e7. PubMed ID: 19616600
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The morphology features of bone marrow in the prefibrotic-early primary myelofibrosis].
    Gong XB; Zhang XH; Lu XG; Tang QS; Gao X; Yang J
    Zhonghua Xue Ye Xue Za Zhi; 2012 Jan; 33(1):25-30. PubMed ID: 22575188
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bone marrow fibrosis and diagnosis of essential thrombocythemia.
    Thiele J; Kvasnicka HM; Vardiman JW; Orazi A; Franco V; Gisslinger H; Birgegard G; Griesshammer M; Tefferi A
    J Clin Oncol; 2009 Dec; 27(34):e220-1; author reply e222-3. PubMed ID: 19858378
    [No Abstract]   [Full Text] [Related]  

  • 8. Proposal for revised diagnostic criteria of essential thrombocythemia and polycythemia vera by the Thrombocythemia Vera Study Group.
    Michiels JJ; Juvonen E
    Semin Thromb Hemost; 1997; 23(4):339-47. PubMed ID: 9263350
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Essential thrombocythaemia with aggressive megakaryocytosis after myelofibrotic transformation.
    Sasaki K; Nannya Y; Nakamura Y; Ichikawa M; Ogawa S; Mitani K
    Hematology; 2021 Dec; 26(1):594-600. PubMed ID: 34402416
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Megakaryocytic morphology and clinical parameters in essential thrombocythemia, polycythemia vera, and primary myelofibrosis with and without JAK2 V617F.
    Vytrva N; Stacher E; Regitnig P; Zinke-Cerwenka W; Hojas S; Hubmann E; Porwit A; Bjorkholm M; Hoefler G; Beham-Schmid C
    Arch Pathol Lab Med; 2014 Sep; 138(9):1203-9. PubMed ID: 25171702
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Different number of circulating CD34 + cells in essential thrombocythemia, prefibrotic/early primary myelofibrosis, and overt primary myelofibrosis.
    Luque Paz D; Cottin L; Lippert E; Robin JB; Bescond C; Genevieve F; Boyer F; Quintin-Roue I; Rousselet MC; Burroni B; Hunault-Berger M; Ugo V; Ianotto JC; Orvain C
    Ann Hematol; 2022 Apr; 101(4):893-896. PubMed ID: 34611719
    [No Abstract]   [Full Text] [Related]  

  • 12. Blood tests may predict early primary myelofibrosis in patients presenting with essential thrombocythemia.
    Carobbio A; Finazzi G; Thiele J; Kvasnicka HM; Passamonti F; Rumi E; Ruggeri M; Rodeghiero F; Luigia Randi M; Bertozzi I; Vannucchi AM; Antonioli E; Gisslinger H; Buxhofer-Ausch V; Gangat N; Rambaldi A; Tefferi A; Barbui T
    Am J Hematol; 2012 Feb; 87(2):203-4. PubMed ID: 22237692
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prodromal myeloproliferative neoplasms: the 2008 WHO classification.
    Kvasnicka HM; Thiele J
    Am J Hematol; 2010 Jan; 85(1):62-9. PubMed ID: 19844986
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [A case of megakaryoblastic leukemia showing features like primary myelofibrosis].
    Takizawa S; Sanada M; Tsukada T; Koike T; Shibata A
    Rinsho Ketsueki; 1984 Dec; 25(12):1967-72. PubMed ID: 6543457
    [No Abstract]   [Full Text] [Related]  

  • 15. [Clinicopathologic conference. Chronic myeloproliferative disease with an increase in platelet count in the differential diagnosis of primary (essential, idiopathic) thrombocythemia (PTH)].
    Zankovich R; Thiele J; Fischer R; Diehl V
    Med Klin (Munich); 1986 Jan; 81(1):31-5. PubMed ID: 3785010
    [No Abstract]   [Full Text] [Related]  

  • 16. Survival and disease progression in essential thrombocythemia are significantly influenced by accurate morphologic diagnosis: an international study.
    Barbui T; Thiele J; Passamonti F; Rumi E; Boveri E; Ruggeri M; Rodeghiero F; d'Amore ES; Randi ML; Bertozzi I; Marino F; Vannucchi AM; Antonioli E; Carrai V; Gisslinger H; Buxhofer-Ausch V; Müllauer L; Carobbio A; Gianatti A; Gangat N; Hanson CA; Tefferi A
    J Clin Oncol; 2011 Aug; 29(23):3179-84. PubMed ID: 21747083
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Problems and pitfalls regarding WHO-defined diagnosis of early/prefibrotic primary myelofibrosis versus essential thrombocythemia.
    Barbui T; Thiele J; Vannucchi AM; Tefferi A
    Leukemia; 2013 Oct; 27(10):1953-8. PubMed ID: 23467025
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Patho-anatomical features of the bone marrow.
    Lennert K; Nagai K; Schwarze EW
    Clin Haematol; 1975 Jun; 4(2):331-51. PubMed ID: 1102191
    [No Abstract]   [Full Text] [Related]  

  • 19. [Essential thrombocythemia that transformed to myelofibrosis after three years].
    Akimoto Y; Ishiyama T; Sano M; Ueno H; Nakamaki T; Hino K; Tomoyasu S; Tsuruoka N
    Rinsho Ketsueki; 1992 Apr; 33(4):520-4. PubMed ID: 1602618
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Subcellular mislocalization of the transcription factor NF-E2 in erythroid cells discriminates prefibrotic primary myelofibrosis from essential thrombocythemia.
    Aumann K; Frey AV; May AM; Hauschke D; Kreutz C; Marx JP; Timmer J; Werner M; Pahl HL
    Blood; 2013 Jul; 122(1):93-9. PubMed ID: 23670178
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.